|
LENZ Lenz Therapeutics Inc 1815776 |
| Balance Sheet |
|
Current Assets
|
220,704,000 |
|
Assets
|
224,007,000 |
|
Current Liabilities
|
7,710,000 |
|
Liabilities
|
8,727,000 |
|
Equity
|
215,280,000 |
|
Shares Out
|
27,497,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-50,313,000 |
|
Investing Cash Flow
|
-142,616,000 |
| Market Analysis |
Market Cap
|
570,555,695 |
|
Price
|
22.50 |
|
BVPS
|
7.83 |
|
PB
|
2.87 |
|
EPS
|
-9.45 |
|
PS
|
0.13 |
|
FCF
|
-192,929,000 |
|
| Dividends |
|
Dividend Amount
|
1.03 |
|
Dividend Yield |
2.89% |
|
| Jan |
Feb |
Mar |
|
|
|
|
Ex: 3/15 |
Pay: 3/21 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LENZ documents filed with the SEC.
LENZ Filings
Clear
